出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年12月
Telehealth and Telemedicine Market – Global Forecasts to 2028
遠隔医療（テレヘルス＆テレメディシン）市場 : コンポーネント［ソフトウェアとサービス（RPM、リアルタイム）、ハードウェア（モニター）］、配信（オンプレミス、クラウドベース）、用途（遠隔放射線学、テレストローク、TelelCU）、エンドユーザー（プロバイダー、支払者）、地域別 – 2028年までの世界予測
Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TelelCU), End User (Provider, Payer) & Region – Global Forecast to 2028
| ページ数 | 379 |
| 図表数 | 452 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The Telehealth and Telemedicine market is projected to reach USD 285.7 billion by 2028 from USD 120.4 billion in 2023, at a CAGR of 23.2% during the forecast period. The growth of telemedicine and telehealth is propelled by increased accessibility to healthcare services, especially in remote areas, and continuous technological advancements, such as improved connectivity and enhanced platforms, fostering better patient engagement and outcomes.
“Cloud based delivery mode segment accounted for a substantial share of the Telehealth and Telemedicine market, by delivery mode in 2022.”
The cloud-based delivery mode is expected to account for the largest share of 78.2% of the global telehealth and telemedicine market in 2022. It is projected to grow at the highest CAGR of 28.6 % during the forecast period. Cloud-based delivery dominates the telehealth and telemedicine market due to its inherent advantages. The accessibility and scalability offered by cloud solutions enable healthcare services from virtually anywhere, bridging gaps in remote or underserved areas. Cost efficiency is heightened through subscription-based models, making these platforms attractive for organizations with budget constraints. Robust security measures, compliance standards, and seamless interoperability make cloud environments secure repositories for sensitive patient data. Real-time collaboration, remote monitoring capabilities, and rapid deployment further enhance the effectiveness of telehealth services. Additionally, cloud platforms ensure quick updates, disaster recovery, and business continuity, collectively driving their widespread adoption in the evolving landscape of healthcare delivery.
“Software and service segment accounted for a substantial share of the Telehealth and Telemedicine market, by component in 2022.”
Based on components, the software & services segment is expected to account for the largest share of 71.3% of the global telehealth and telemedicine market in 2022. The software and services segment holds a significant share as a component in the telehealth and telemedicine market. This prominence is driven by the crucial role that software applications and associated services play in facilitating remote healthcare delivery. Telehealth platforms rely heavily on advanced software solutions to enable virtual consultations, patient monitoring, and seamless data exchange. Additionally, the provision of supportive services such as telemedicine consultation support, data analytics, and integration services further solidifies the importance of the software and services component. As the telehealth and telemedicine landscape continues to evolve, the software and services segment remains a cornerstone, contributing substantially to the market’s growth and efficacy.
“Providers segment accounted for a considerable share in the Telehealth and Telemedicine market, by end user in 2022”
In 2022, the provider segment played a significant role in the telehealth and telemedicine market, contributing to a substantial share. This prominence is attributed to This is attributed to the increased adoption of remote monitoring for chronically ill and old aged patients, advancements in telehealth monitoring devices, and the increased number of telespecialty services offered by providers..
“Teleradiology segment accounted for the largest share in Telehealth and Telemedicine market by Application in 2022”
In 2022, teleradiology segment emerged as the leading contributor to the Telehealth and Telemedicine market, holding the largest share. Factors such as an increase in imaging practices, an increase in teleradiology workflow adoption by healthcare providers, and the streamlining and regulation of teleradiology practices are driving the market growth. The teleradiology segment is expected to account for the largest share of 22.2% of the global telehealth and telemedicine market in 2022.
“North America to witness the substantial growth rate during the forecast period.”
The global market is led by the United States, experiencing a noteworthy CAGR of 24.3% and reaching a valuation of US$ 289.7 billion in the forecast period. The surge is propelled by factors such as the prevalence of chronic diseases, an aging population, and cost-effective healthcare services, contributing to the growth of telehealth and telemedicine in the United States. The market sees continuous expansion due to increased healthcare infrastructure, expenditures, and innovative technologies. Government initiatives and the active involvement of key vendors further amplify market size, marking a substantial increase from the historical CAGR of 24.3% between 2023 and 2028.
The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
• By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, ROW-10%
Key Players in the Telehealth and Telemedicine Solutions Market
Prominent players in the Telehealth and Telemedicine market include Koninklijke Philips, N.V (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Oracle (US), Siemens Healthcare GmbH (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Iron Bow Technologies (US), American Well (US), Teladoc Health, Inc. (US), AMC Health (US), TeleSpecialists(US), Doctor On Demand by Included Health, Inc. (US), MDLIVE (US), GlobalMedia Group, LLC (US), Medvivo Group Ltd. (UK), Medweb(US), VSee (US), Imedi Plus (China), Zipnosis (US), ACL Digital (US), iCliniq (US), Boston Scientific Cardiac Diagnostics Inc. (US), Resideo Technologies Inc.(US).
Research Coverage:
The report analyzes the Telehealth and Telemedicine Market and aims to estimate the market size and future growth potential of various market segments, based on components,mode of delivery, application , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
n Analysis of key drivers (Growing geriatric population and need to expand healthcare access, Rising prevalence of chronic conditions and cost-benefits of telehealth and telemedicine, Shortage of physicians, Advancements in telecommunications, and Government support and rising awareness), restraints (regulatory variations across regions, fraud in telemedicine and telehealth), opportunities (High utility in combating infectious diseases and epidemics, use of innovative technologies like blockchain, AI and virtual assistants), and challenges (Inability to ascertain hygiene and cleanlinessinfluencing the growth of the Telehealth and Telemedicine market.
n Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the Telehealth and Telemedicine market.
n Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
n Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the Telehealth and Telemedicine market
n Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the Telehealth and Telemedicine market like Koninklijke Philips, N.V (Netherlands), Medtronic plc (Ireland), GE Healthcare (US), Oracle (US), Siemens Healthcare GmbH (Germany), Cisco Systems (US) etc.
Table of Contents
1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 48
1.2.1 TELEHEALTH 48
1.2.2 TELEMEDICINE 49
1.3 INCLUSIONS & EXCLUSIONS 49
1.4 MARKET SCOPE 50
1.4.1 MARKETS COVERED 50
1.4.2 REGIONS COVERED 51
1.4.3 YEARS CONSIDERED 51
1.4.4 CURRENCY CONSIDERED 52
1.5 RESEARCH LIMITATIONS 52
1.5.1 SCOPE-RELATED LIMITATIONS 52
1.5.2 METHODOLOGY-RELATED LIMITATIONS 52
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 53
1.7.1 RECESSION IMPACT: TELEHEALTH & TELEMEDICINE MARKET 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
FIGURE 1 RESEARCH METHODOLOGY: TELEHEALTH & TELEMEDICINE MARKET 54
FIGURE 2 RESEARCH DESIGN 55
2.1.1 SECONDARY DATA 55
2.1.1.1 Secondary sources 56
2.1.2 PRIMARY DATA 57
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION 58
2.1.2.1 Primary sources 58
2.1.2.2 Key insights from primary sources 58
2.2 MARKET SIZE ESTIMATION 59
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 59
FIGURE 5 ESTIMATION OF MARKET SIZE FOR REMOTE PATIENT MONITORING SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH 60
FIGURE 6 ESTIMATION OF MARKET SIZE FOR REAL-TIME INTERACTION SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH 60
FIGURE 7 ESTIMATION OF MARKET SIZE FOR STORE-AND-FORWARD SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH 61
FIGURE 8 ESTIMATION OF GLOBAL TELEHEALTH & TELEMEDICINE MARKET SIZE THROUGH ADOPTION-BASED APPROACH 61
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 63
FIGURE 9 DATA TRIANGULATION METHODOLOGY 63
2.4 STUDY ASSUMPTIONS 64
2.5 RISK ASSESSMENT 64
2.6 IMPACT OF ECONOMIC RECESSION ON TELEHEALTH & TELEMEDICINE MARKET 64
3 EXECUTIVE SUMMARY 66
FIGURE 10 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 66
FIGURE 11 TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2023 VS. 2028 (USD MILLION) 67
FIGURE 12 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 67
FIGURE 13 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 68
FIGURE 14 REGIONAL SNAPSHOT: TELEHEALTH & TELEMEDICINE MARKET 69
4 PREMIUM INSIGHTS 70
4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 70
FIGURE 15 SHORTAGE OF MEDICAL STAFF, RISE IN CHRONIC DISEASES, AND INCREASED GERIATRIC POPULATION TO DRIVE MARKET 70
4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT AND COUNTRY, 2022 71
FIGURE 16 SOFTWARE & SERVICES SEGMENT AND US DOMINATED NORTH AMERICAN MARKET IN 2022 71
4.3 GEOGRAPHICAL GROWTH OPPORTUNITIES: TELEHEALTH & TELEMEDICINE MARKET 72
FIGURE 17 CHINA TO ACCOUNT FOR HIGHEST CAGR DURING FORECAST PERIOD 72
4.4 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2021–2028 73
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 73
4.5 DEVELOPED VS. EMERGING ECONOMIES: TELEHEALTH & TELEMEDICINE MARKET 73
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 73
5 MARKET OVERVIEW 74
5.1 INTRODUCTION 74
5.2 MARKET DYNAMICS 74
FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: TELEHEALTH & TELEMEDICINE MARKET 74
TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS 75
5.2.1 DRIVERS 76
5.2.1.1 Growing geriatric population and increasing need to expand healthcare access 76
TABLE 2 INCREASE IN POPULATION, 2022, 2030, AND 2050, BY MEDIUM SCENARIO (MILLION) 76
5.2.1.2 Rising prevalence of chronic conditions and cost-benefits of telehealth & telemedicine services 77
TABLE 3 CHRONIC DISEASES AND THEIR COST BURDEN IN US: POTENTIAL FOR SAVINGS 77
5.2.1.3 Shortage of skilled healthcare professionals 78
5.2.1.4 Advancements in telecommunication technologies 78
5.2.1.5 Increased government support and favorable reimbursement policies 78
5.2.2 RESTRAINTS 79
5.2.2.1 Regulatory variations across regions 79
TABLE 4 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 79
5.2.2.2 Increase in fraud in telehealth practices 80
5.2.2.3 Violation of medical ethics 81
5.2.3 OPPORTUNITIES 81
5.2.3.1 Increased utility of telemedicine against infectious diseases and epidemics 81
5.2.3.2 Use of blockchain technology in healthcare industry 81
5.2.3.3 Increased use of artificial intelligence and big data analytics 82
5.2.3.4 Growing demand for virtual care 83
5.2.4 CHALLENGES 84
5.2.4.1 Inability to maintain hygiene and cleanliness standards 84
5.2.4.2 Behavioral barriers, healthcare affordability, and lack of awareness 84
5.3 INDUSTRY TRENDS 85
TABLE 5 TRENDS IN TELEHEALTH & TELEMEDICINE MARKET 85
5.3.1 OVERVIEW OF USE CASES 86
TABLE 6 OVERVIEW OF TELEHEALTH USE CASES 88
5.4 TECHNOLOGY ANALYSIS 89
5.4.1 MACHINE LEARNING 89
5.4.2 ARTIFICIAL INTELLIGENCE 90
5.4.3 INTERNET OF THINGS 90
5.4.4 BLOCKCHAIN TECHNOLOGY 90
5.4.5 CLOUD COMPUTING 91
5.4.6 DATA ANALYTICS 91
5.4.7 EXTENDED REALITY 91
5.5 CASE STUDY ANALYSIS 92
5.5.1 CASE STUDY 1 92
5.5.2 CASE STUDY 2 93
5.6 ECOSYSTEM MARKET MAP 93
FIGURE 21 ECOSYSTEM MARKET MAP: TELEHEALTH & TELEMEDICINE MARKET 97
5.7 VALUE CHAIN ANALYSIS 98
FIGURE 22 VALUE CHAIN ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET 99
5.8 PORTER’S FIVE FORCES ANALYSIS 99
TABLE 7 PORTER’S FIVE FORCES ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET 99
5.8.1 THREAT OF NEW ENTRANTS 100
5.8.2 THREAT OF SUBSTITUTES 100
5.8.3 BARGAINING POWER OF BUYERS 100
5.8.4 BARGAINING POWER OF SUPPLIERS 100
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 100
5.9 PATENT ANALYSIS 100
5.9.1 PATENT PUBLICATION TRENDS 100
FIGURE 23 PATENT PUBLICATION TRENDS, 2014–2023 101
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 101
FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE PATENTS, JANUARY 2013– NOVEMBER 2023 102
FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR TELEHEALTH & TELEMEDICINE PATENTS, JANUARY 2014–OCTOBER 2023 102
5.9.3 LIST OF MAJOR PATENTS 103
TABLE 8 KEY PATENTS IN TELEHEALTH & TELEMEDICINE MARKET 103
5.10 TARIFF & REGULATORY LANDSCAPE 104
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 12 REGULATORY STANDARDS IN TELEHEALTH & TELEMEDICINE MARKET 107
5.10.2 REGULATORY ANALYSIS 108
TABLE 13 REGULATORY REQUIREMENTS IN NORTH AMERICA 108
TABLE 14 REGULATORY REQUIREMENTS IN EUROPE 109
TABLE 15 REGULATORY REQUIREMENTS IN ASIA PACIFIC 109
TABLE 16 REGULATORY REQUIREMENTS IN LATIN AMERICA 110
TABLE 17 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 110
5.11 TRADE ANALYSIS 111
5.11.1 TRADE ANALYSIS FOR TELEHEALTH & TELEMEDICINE DEVICES 111
FIGURE 26 IMPORTS OF PRODUCTS UNDER HSN CODE 90189099, BY COUNTRY, 2022 (USD THOUSAND) 111
FIGURE 27 EXPORTS OF PRODUCTS UNDER HSN CODE 90189099, BY COUNTRY, 2022 (USD THOUSAND) 112
5.12 PRICING ANALYSIS 112
5.12.1 COSTS INVOLVED IN TELEMEDICINE DEVICES 112
5.12.2 AVERAGE SELLING PRICE FOR TELEHEALTH & TELEMEDICINE DEVICES, BY KEY PLAYER 113
5.12.3 INDICATIVE PRICING ANALYSIS OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION 113
5.12.4 PRICING MODELS 113
5.13 REIMBURSEMENT ANALYSIS 114
5.13.1 TYPES OF VIRTUAL SERVICES TO MEDICARE BENEFICIARIES 114
TABLE 18 MEDICARE TELEMEDICINE SERVICES AND HCPCS/CPT CODES 114
5.14 INVESTMENT LANDSCAPE 115
FIGURE 28 INVESTOR DEALS AND FUNDING IN TELEHEALTH & TELEMEDICINE DROPPED IN 2022 115
FIGURE 29 TOP FUNDED GLOBAL DIGITAL HEALTH CATEGORIES IN 2021 116
FIGURE 30 MOST VALUED TELEHEALTH & TELEMEDICINE FIRMS IN 2022 (USD BILLION) 117
5.15 KEY CONFERENCES & EVENTS 117
TABLE 19 LIST OF KEY CONFERENCES & EVENTS, 2023–2024 117
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 118
FIGURE 31 REVENUE SHIFT IN TELEHEALTH & TELEMEDICINE MARKET 118
5.17 KEY STAKEHOLDERS & BUYING CRITERIA 119
5.17.1 KEY STAKEHOLDERS 119
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 119
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 119
5.17.2 BUYING CRITERIA 120
FIGURE 33 KEY BUYING CRITERIA 120
TABLE 21 KEY BUYING CRITERIA FOR TELEHEALTH & TELEMEDICINE MARKET 120
5.18 UNMET NEEDS 121
TABLE 22 UNMET NEED IN TELEHEALTH & TELEMEDICINE MARKET 121
6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 123
6.1 INTRODUCTION 124
TABLE 23 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 124
6.2 SOFTWARE & SERVICES 124
TABLE 24 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 25 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 26 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 27 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 28 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 29 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 30 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 127
6.2.1 SOFTWARE & SERVICES, BY TYPE 127
6.2.1.1 Remote patient monitoring 127
6.2.1.1.1 Convenience of tracking patient vitals from different places to drive segment 127
TABLE 31 REMOTE PATIENT MONITORING MARKET, BY REGION,
2021–2028 (USD MILLION) 129
6.2.1.2 Real-time interaction 129
6.2.1.2.1 Synchronous nature and potential for better healthcare access to drive segment 129
TABLE 32 REAL-TIME INTERACTION MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.2.1.3 Store and forward 130
6.2.1.3.1 Easy monitoring of vital signs for long-term chronic care without physical presence to drive segment 130
TABLE 33 STORE AND FORWARD MARKET, BY REGION, 2021–2028 (USD MILLION) 131
6.2.2 SOFTWARE & SERVICES, BY REVENUE MODEL 131
TABLE 34 TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 131
6.2.2.1 One-time purchase 132
6.2.2.1.1 Increasing government funding and collaborations with healthcare organizations in rural areas to drive segment 132
TABLE 35 ONE-TIME PURCHASE MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.2.2.2 Subscription-based 133
6.2.2.2.1 Technological advancements and fixed recurring fees for telehealth consultations to drive segment 133
TABLE 36 SUBSCRIPTION-BASED MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.2.2.3 Pay-per-use 133
6.2.2.3.1 Lack of adequate reimbursement policies to limit segment 133
TABLE 37 PAY-PER-USE MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.3 HARDWARE 134
TABLE 38 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 39 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 40 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 41 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 42 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 43 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 44 TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 137
6.3.1 MONITORS 137
6.3.1.1 Increase in remote monitoring and rising adoption of telemedicine devices to drive segment 137
TABLE 45 MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
6.3.2 MEDICAL PERIPHERAL DEVICES 138
TABLE 46 MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 47 MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 139
6.3.2.1 Blood pressure monitors 139
6.3.2.1.1 Increasing prevalence of hypertension and obesity to drive segment 139
TABLE 48 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 140
6.3.2.2 Blood glucose meters 140
6.3.2.2.1 Growth in diabetic population to drive segment 140
TABLE 49 BLOOD GLUCOSE METERS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
6.3.2.3 Weight scales 141
6.3.2.3.1 Increasing prevalence of obesity to drive segment 141
TABLE 50 WEIGHT SCALES MARKET, BY REGION, 2021–2028 (USD MILLION) 142
6.3.2.4 Pulse oximeters 142
6.3.2.4.1 Rising awareness about self-monitoring and ease of usage to drive segment 142
TABLE 51 PULSE OXIMETER MARKET, BY REGION, 2021–2028 (USD MILLION) 142
6.3.2.5 Peak flow meters 143
6.3.2.5.1 Rapid assessment of lung conditions and growth in respiratory complications to drive segment 143
TABLE 52 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
6.3.2.6 ECG monitors 143
6.3.2.6.1 Rising incidence of cardiovascular diseases to drive segment 143
TABLE 53 ECG MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION) 144
6.3.2.7 Other medical peripheral devices 144
TABLE 54 OTHER MEDICAL PERIPHERAL PRODUCTS OFFERED BY KEY PLAYERS 144
TABLE 55 OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 145
7 TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY 146
7.1 INTRODUCTION 147
TABLE 56 TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 147
7.2 CLOUD-BASED DELIVERY 147
7.2.1 CLOUD-BASED DELIVERY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 147
TABLE 57 TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 58 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 59 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 60 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 61 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 62 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 150
7.3 ON-PREMISE DELIVERY 150
7.3.1 ENHANCED CONTROL OF SOFTWARE AND EASY REUSE OF EXISTING INFRASTRUCTURE TO DRIVE MARKET 150
TABLE 63 TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY REGION, 2021–2028 (USD MILLION) 151
TABLE 64 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 65 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 66 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 67 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 68 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION) 153
8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 154
8.1 INTRODUCTION 155
TABLE 69 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
8.2 TELECONSULTATION 155
8.2.1 INCREASED NEED FOR AT-HOME FACILITIES AND SHORTAGE OF MEDICAL STAFF TO DRIVE MARKET 155
TABLE 70 TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 71 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 72 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 73 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 74 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 75 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION) 158
8.3 TELEICU 158
8.3.1 INCREASING NUMBER OF PATIENTS IN EMERGENCY DEPARTMENTS AND STAFF SHORTAGE IN RURAL AREAS TO DRIVE MARKET 158
TABLE 76 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 77 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 78 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 79 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 80 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 81 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION) 161
8.4 TELEPSYCHIATRY 162
8.4.1 SHORTAGE OF MENTAL HEALTH PRACTITIONERS AND FAVORABLE REIMBURSEMENT SCENARIO TO DRIVE MARKET 162
TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 83 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 84 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 85 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 86 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 87 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION) 165
8.5 TELERADIOLOGY 165
8.5.1 TELERADIOLOGY TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 165
TABLE 88 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2021–2028 (USD MILLION) 166
TABLE 89 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 90 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 91 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 92 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 93 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
8.6 TELESTROKE 169
8.6.1 RISING INCIDENCE OF STROKE AND INCREASING GERIATRIC POPULATION TO DRIVE MARKET 169
TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION, 2021–2028 (USD MILLION) 169
TABLE 95 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 96 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 97 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 98 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 99 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION) 171
8.7 TELEDERMATOLOGY 171
8.7.1 RISING PREVALENCE OF SKIN DISEASES AND GROWING USE OF HD CAMERAS FOR SKIN DIAGNOSIS TO DRIVE MARKET 171
TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 101 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 102 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 103 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 104 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 105 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 174
8.8 OTHER APPLICATIONS 175
TABLE 106 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 175
TABLE 107 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 108 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 109 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 110 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 111 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 177
9 TELEHEALTH & TELEMEDICINE MARKET, BY END USER 178
9.1 INTRODUCTION 179
TABLE 112 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 179
9.2 PROVIDERS 179
TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 114 TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 180
TABLE 115 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 116 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 117 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 118 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 182
TABLE 119 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 182
9.2.1 HOSPITALS & CLINICS 182
9.2.1.1 Growing incidence of chronic diseases and rising demand for high-quality care to drive segment 182
TABLE 120 HOSPITALS & CLINICS MARKET, BY REGION, 2021–2028 (USD MILLION) 183
9.2.2 LONG-TERM CARE CENTERS AND ASSISTED LIVING FACILITIES 183
9.2.2.1 Increasing geriatric population and rising need for prolonged treatment for chronic diseases to drive segment 183
TABLE 121 LONG-TERM CARE CENTERS AND ASSISTED LIVING FACILITIES MARKET, BY REGION, 2021–2028 (USD MILLION) 184
9.3 PAYERS 184
TABLE 122 TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 185
TABLE 123 TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 124 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 125 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 126 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 127 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 128 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 187
9.3.1 PUBLIC PAYERS 187
9.3.1.1 Increasing investments by public payers to drive segment 187
TABLE 129 PUBLIC PAYERS MARKET, BY REGION, 2021–2028 (USD MILLION) 188
9.3.2 PRIVATE PAYERS 188
9.3.2.1 Expansion of telehealth services to mental health and substance usage to drive segment 188
TABLE 130 PRIVATE PAYERS MARKET, BY REGION, 2021–2028 (USD MILLION) 189
9.4 PATIENTS 189
9.4.1 RISING PREVALENCE OF CHRONIC DISEASES AND EMERGENCE OF ADVANCED WEARABLE MONITORS TO DRIVE MARKET 189
TABLE 131 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION) 190
TABLE 132 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 133 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 134 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 135 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 136 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 192
9.5 OTHER END USERS 192
TABLE 137 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 193
TABLE 138 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 139 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 140 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 141 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 142 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 195
10 TELEHEALTH & TELEMEDICINE MARKET, BY REGION 196
10.1 INTRODUCTION 197
FIGURE 34 GEOGRAPHIC SNAPSHOT: TELEHEALTH & TELEMEDICINE MARKET, 2022 197
TABLE 143 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2021–2028 (USD MILLION) 198
10.2 NORTH AMERICA 198
FIGURE 35 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 199
TABLE 144 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 145 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 200
TABLE 146 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 147 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 201
TABLE 148 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 149 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 150 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 202
TABLE 151 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 203
TABLE 152 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 203
TABLE 153 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 204
TABLE 154 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 204
10.2.1 NORTH AMERICA: RECESSION IMPACT 204
10.2.2 US 205
10.2.2.1 US to dominate North American market during forecast period 205
TABLE 155 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 207
TABLE 156 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 157 US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 207
TABLE 158 US: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 159 US: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 160 US: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 209
TABLE 161 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 209
TABLE 162 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 210
TABLE 163 US: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 210
TABLE 164 US: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 210
10.2.3 CANADA 211
10.2.3.1 Increasing geriatric population and rising government healthcare expenditure to drive market 211
TABLE 165 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 212
TABLE 166 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 167 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 212
TABLE 168 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 169 CANADA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 170 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 213
TABLE 171 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214
TABLE 172 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 214
TABLE 173 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 215
TABLE 174 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 215
10.3 EUROPE 215
TABLE 175 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 176 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 216
TABLE 177 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 178 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 217
TABLE 179 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 180 EUROPE: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 181 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 218
TABLE 182 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 183 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 219
TABLE 184 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 220
TABLE 185 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 220
10.3.1 EUROPE: RECESSION IMPACT 220
10.3.2 GERMANY 221
10.3.2.1 Rapid digitization of healthcare systems and repealed ban on remote treatment to drive market 221
TABLE 186 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 222
TABLE 187 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 188 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 222
TABLE 189 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 190 GERMANY: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 191 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 223
TABLE 192 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 193 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 224
TABLE 194 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 225
TABLE 195 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 225
10.3.3 FRANCE 225
10.3.3.1 Favorable reimbursement and investment scenario for remote healthcare services to drive market 225
TABLE 196 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 226
TABLE 197 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 198 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 227
TABLE 199 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 200 FRANCE: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 201 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 228
TABLE 202 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 228
TABLE 203 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 229
TABLE 204 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 229
TABLE 205 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 229
10.3.4 UK 230
10.3.4.1 Need to manage growing government healthcare expenditure and shortage of medical staff to drive market 230
TABLE 206 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 230
TABLE 207 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 208 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 231
TABLE 209 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 210 UK: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 211 UK: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 232
TABLE 212 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 233
TABLE 213 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 233
TABLE 214 UK: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 234
TABLE 215 UK: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 234
10.3.5 ITALY 234
10.3.5.1 Established telehealth and telespecialty practices and increased geriatric population to drive market 234
TABLE 216 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 235
TABLE 217 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 218 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 236
TABLE 219 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 220 ITALY: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 221 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 237
TABLE 222 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 237
TABLE 223 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 238
TABLE 224 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 238
TABLE 225 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 238
10.3.6 SPAIN 239
10.3.6.1 Rising incidence of chronic diseases and well-organized healthcare system to drive market 239
TABLE 226 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 239
TABLE 227 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 228 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 240
TABLE 229 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 230 SPAIN: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 231 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 241
TABLE 232 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 242
TABLE 233 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 242
TABLE 234 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 243
TABLE 235 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 243
10.3.7 REST OF EUROPE 243
TABLE 236 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 244
TABLE 237 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 238 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 245
TABLE 239 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 240 REST OF EUROPE: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 241 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 246
TABLE 242 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 247
TABLE 243 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 247
TABLE 244 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 248
TABLE 245 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 248
10.4 ASIA PACIFIC 248
FIGURE 36 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 250
TABLE 246 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 251
TABLE 247 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 251
TABLE 248 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 249 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 252
TABLE 250 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 251 ASIA PACIFIC: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 252 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 253
TABLE 253 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 254
TABLE 254 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 254
TABLE 255 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 255
TABLE 256 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 255
10.4.1 ASIA PACIFIC: RECESSION IMPACT 255
10.4.2 CHINA 256
10.4.2.1 Opportunities for advanced internet-based telehealth platforms to drive market 256
TABLE 257 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 256
TABLE 258 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 259 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 257
TABLE 260 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 261 CHINA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 262 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 258
TABLE 263 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 259
TABLE 264 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 259
TABLE 265 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 260
TABLE 266 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 260
10.4.3 JAPAN 260
10.4.3.1 Rise in geriatric population and well-established health insurance system to drive market 260
TABLE 267 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 261
TABLE 268 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 269 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 262
TABLE 270 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 271 JAPAN: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 272 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 263
TABLE 273 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 264
TABLE 274 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 264
TABLE 275 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 265
TABLE 276 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 265
10.4.4 INDIA 265
10.4.4.1 Favorable government policies and high density of rural population to drive market 265
TABLE 277 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 267
TABLE 278 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 279 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 267
TABLE 280 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 281 INDIA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 282 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 268
TABLE 283 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 269
TABLE 284 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 269
TABLE 285 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 270
TABLE 286 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 270
10.4.5 AUSTRALIA 270
10.4.5.1 Favorable government initiatives and healthcare policies to drive market 270
TABLE 287 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 271
TABLE 288 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 289 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 272
TABLE 290 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 291 AUSTRALIA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 292 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 273
TABLE 293 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 273
TABLE 294 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 274
TABLE 295 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 274
TABLE 296 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 274
10.4.6 REST OF ASIA PACIFIC 275
TABLE 297 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 275
TABLE 298 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 299 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 276
TABLE 300 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 301 REST OF ASIA PACIFIC: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 302 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 277
TABLE 303 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 278
TABLE 304 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 278
TABLE 305 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 279
TABLE 306 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 279
10.5 LATIN AMERICA 279
TABLE 307 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 280
TABLE 308 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 280
TABLE 309 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 310 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 281
TABLE 311 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 312 LATIN AMERICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 313 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 282
TABLE 314 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 283
TABLE 315 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 283
TABLE 316 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 284
TABLE 317 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 284
10.5.1 LATIN AMERICA: RECESSION IMPACT 284
10.5.2 BRAZIL 285
10.5.2.1 Growing focus on reducing government healthcare expenditure to drive market 285
TABLE 318 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 285
TABLE 319 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 320 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 286
TABLE 321 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 322 BRAZIL: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 287
TABLE 323 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 287
TABLE 324 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 288
TABLE 325 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 288
TABLE 326 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 289
TABLE 327 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 289
10.5.3 MEXICO 289
10.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market 289
TABLE 328 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 290
TABLE 329 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 330 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 290
TABLE 331 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 332 MEXICO: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 333 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 291
TABLE 334 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 292
TABLE 335 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 292
TABLE 336 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 293
TABLE 337 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 293
10.5.4 REST OF LATIN AMERICA 293
TABLE 338 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 294
TABLE 339 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 340 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 295
TABLE 341 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 342 REST OF LATIN AMERICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 343 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 296
TABLE 344 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 297
TABLE 345 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 297
TABLE 346 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 298
TABLE 347 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 298
10.6 MIDDLE EAST & AFRICA 298
TABLE 348 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 299
TABLE 349 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 299
TABLE 350 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 351 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 300
TABLE 352 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 353 MIDDLE EAST & AFRICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 354 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 301
TABLE 355 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 302
TABLE 356 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 302
TABLE 357 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 303
TABLE 358 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 303
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 303
10.6.2 GCC COUNTRIES 304
10.6.2.1 Rising focus on expanding and improving present health infrastructure to drive market 304
TABLE 359 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 305
TABLE 360 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 361 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 305
TABLE 362 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 363 GCC COUNTRIES: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 364 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 306
TABLE 365 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 307
TABLE 366 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 307
TABLE 367 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 308
TABLE 368 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 308
10.6.3 REST OF MIDDLE EAST & AFRICA 308
TABLE 369 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 309
TABLE 370 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 371 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 310
TABLE 372 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 373 REST OF MIDDLE EAST & AFRICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 374 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 311
TABLE 375 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 312
TABLE 376 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 312
TABLE 377 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 313
TABLE 378 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 313
11 COMPETITIVE LANDSCAPE 314
11.1 INTRODUCTION 314
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 314
FIGURE 37 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS, JANUARY 2020– NOVEMBER 2023 315
11.3 REVENUE SHARE ANALYSIS 316
FIGURE 38 REVENUE SHARE ANALYSIS, 2018–2022 316
11.4 MARKET SHARE ANALYSIS 316
FIGURE 39 MARKET SHARE ANALYSIS, 2022 317
11.5 COMPANY EVALUATION MATRIX 319
11.5.1 STARS 319
11.5.2 EMERGING LEADERS 319
11.5.3 PERVASIVE PLAYERS 319
11.5.4 PARTICIPANTS 319
FIGURE 40 COMPANY EVALUATION MATRIX, 2022 320
11.5.5 COMPANY FOOTPRINT 321
TABLE 379 OVERALL FOOTPRINT 321
TABLE 380 PRODUCT FOOTPRINT 322
TABLE 381 REGIONAL FOOTPRINT 323
11.6 START-UP/SME EVALUATION MATRIX 324
11.6.1 PROGRESSIVE COMPANIES 324
11.6.2 RESPONSIVE COMPANIES 324
11.6.3 DYNAMIC COMPANIES 324
11.6.4 STARTING BLOCKS 324
FIGURE 41 START-UP/SME EVALUATION MATRIX, 2022 325
11.6.5 COMPETITIVE BENCHMARKING 326
TABLE 382 DETAILED LIST OF KEY START-UPS/SMES 326
TABLE 383 COMPETITIVE BENCHMARKING OF START-UPS/SMES 328
11.7 COMPETITIVE SCENARIOS AND TRENDS 329
11.7.1 KEY PRODUCT LAUNCHES 329
TABLE 384 KEY PRODUCT LAUNCHES, JANUARY 2020–SEPTEMBER 2023 329
11.7.2 KEY DEALS 329
TABLE 385 KEY DEALS, JANUARY 2020–SEPTEMBER 2023 330
11.7.3 OTHER KEY DEVELOPMENTS 331
TABLE 386 OTHER KEY DEVELOPMENTS, JANUARY 2020–SEPTEMBER 2023 331
12 COMPANY PROFILES 332
12.1 KEY PLAYERS 332
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 KONINKLIJKE PHILIPS N.V. 332
TABLE 387 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 332
FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 333
12.1.2 MEDTRONIC 337
TABLE 388 MEDTRONIC: COMPANY OVERVIEW 337
FIGURE 43 MEDTRONIC: COMPANY SNAPSHOT (2022) 338
12.1.3 GE HEALTHCARE 342
TABLE 389 GE HEALTHCARE: COMPANY OVERVIEW 342
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 343
12.1.4 SIEMENS HEALTHINEERS AG 347
TABLE 390 SIEMENS HEALTHINEERS GMBH: COMPANY OVERVIEW 347
FIGURE 45 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 348
12.1.5 CISCO SYSTEMS, INC. 351
TABLE 391 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 351
FIGURE 46 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 352
12.1.6 ORACLE 354
TABLE 392 ORACLE: COMPANY OVERVIEW 354
FIGURE 47 ORACLE: COMPANY SNAPSHOT (2022) 355
12.1.7 ASAHI KASEI CORPORATION 358
TABLE 393 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 358
FIGURE 48 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 359
12.1.8 IRON BOW TECHNOLOGIES 361
TABLE 394 IRON BOW TECHNOLOGIES: COMPANY OVERVIEW 361
12.1.9 AMERICAN WELL 363
TABLE 395 AMERICAN WELL: COMPANY OVERVIEW 363
12.1.10 TELADOC HEALTH, INC. 366
TABLE 396 TELADOC HEALTH, INC.: COMPANY OVERVIEW 366
FIGURE 49 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2022) 367
12.1.11 AMC HEALTH 370
TABLE 397 AMC HEALTH: COMPANY OVERVIEW 370
12.1.12 TELESPECIALISTS 372
TABLE 398 TELESPECIALISTS: COMPANY OVERVIEW 372
12.1.13 DOCTOR ON DEMAND, INC. 374
TABLE 399 DOCTOR ON DEMAND, INC.: COMPANY OVERVIEW 374
12.1.14 EVERNORTH HEALTH, INC. 376
TABLE 400 EVERNORTH HEALTH, INC.: COMPANY OVERVIEW 376
FIGURE 50 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT (2022) 376
12.1.15 GLOBAL MEDIA GROUP LLC 378
TABLE 401 GLOBAL MEDIA GROUP: COMPANY OVERVIEW 378
12.1.16 MEDVIVO GROUP LTD. 380
TABLE 402 MEDVIVO GROUP LTD.: COMPANY OVERVIEW 380
12.2 OTHER PLAYERS 381
12.2.1 MEDWEB 381
12.2.2 VSEE 381
12.2.3 IMEDI PLUS 382
12.2.4 ZIPNOSIS 382
12.2.5 ACL DIGITAL 383
12.2.6 ICLINIQ 384
12.2.7 BOSTON SCIENTIFIC CARDIAC DIAGNOSTICS INC. 384
12.2.8 RESIDEO LIFE CARE SOLUTIONS 385
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 386
13.1 DISCUSSION GUIDE 386
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 391
13.3 CUSTOMIZATION OPTIONS 393
13.4 RELATED REPORTS 393
13.5 AUTHOR DETAILS 394